A detailed history of Superstring Capital Management LP transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Superstring Capital Management LP holds 1,466,934 shares of FATE stock, worth $2.44 Million. This represents 4.49% of its overall portfolio holdings.

Number of Shares
1,466,934
Previous 497,360 194.94%
Holding current value
$2.44 Million
Previous $1.63 Billion 214.73%
% of portfolio
4.49%
Previous 2.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.12 - $5.57 $3.03 Million - $5.4 Million
969,574 Added 194.94%
1,466,934 $5.13 Billion
Q2 2024

Aug 14, 2024

SELL
$3.26 - $7.08 $1.38 Million - $3 Million
-423,116 Reduced 45.97%
497,360 $1.63 Billion
Q1 2024

May 15, 2024

BUY
$3.54 - $8.35 $257,191 - $606,652
72,653 Added 8.57%
920,476 $6.76 Billion
Q4 2023

Feb 14, 2024

BUY
$1.65 - $3.94 $1.4 Million - $3.34 Million
847,823 New
847,823 $3.17 Billion

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.